Asan Medical Center

This study tests whether a drug called INCMGA00012 (a PD-1 inhibitor) can help prevent esophageal cancer from returning after patients have completed chemoradiation. About 110 adults with locally advanced esophageal squamous cell carcinoma will be randomly assigned to receive the…

This study tests a drug called enavogliflozin (a type of SGLT2 inhibitor) in 541 adults with heart failure and a leaky tricuspid valve. Participants take the drug or a placebo for 18 months. The goal is to see if the drug reduces heart-related deaths, hospital stays, and valve wo…

This study looks at whether doing a heart valve repair procedure early (called percutaneous mitral commissurotomy) is better than waiting and using standard care for people who have moderate mitral stenosis but no symptoms. The goal is to see if early treatment can prevent seriou…

This study looks at whether adults with chronic hepatitis B who have been on antiviral drugs for at least 2 years and have no liver scarring can safely stop taking them. The 140 participants will be monitored for virus return and liver problems. The goal is to see if stopping tre…

This study looks at 364 people with mild to moderate aortic valve stenosis (a narrowing of the heart's main valve). Researchers compare those with high levels of lipoprotein(a) (a type of fat in the blood) to those with low levels, to see if the valve disease gets worse faster. T…